![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Sanofi and GSK Partner Up on COVID-19 Vaccine
Sanofi and GSK Partner Up on COVID-19 Vaccine
![Partner Up, blocks](https://www.fdanews.com/ext/resources/test/Drug-Images4/Partner-Up-blocks.gif?t=1593635821&width=430)
Sanofi and GlaxoSmithKline (GSK) have entered into a partnership to develop a COVID-19 vaccine that includes an adjuvant to boost the immune response.
Sanofi will contribute its S-protein COVID-19 antigen while GSK will provide its adjuvant technology.
The drugmakers plan to begin phase 1 clinical trials in the second half of 2020 and hope to have a vaccine available by the second half of 2021.
Upcoming Events
-
18Jul
-
21Oct